# West Virginia Clinical and Translational Science Institute: Improving Health through Partnerships and Transformative Research

> **NIH NIH U54** · WEST VIRGINIA UNIVERSITY · 2020 · $1,573,155

## Abstract

Emergence of a novel coronavirus, now known as severe acute respiratory syndrome coronavirus
2 (SARS CoV-2), has resulted in human disease (COVID-19) that has swept the globe in
pandemic proportions with more than eight million confirmed cases and >440,000 deaths to date.
Surges of COVID-19 have occurred throughout the United States (US) with urban centers such
as New York City and New Orleans hardest hit. COVID-19 clinical descriptions have evolved
from what was initially felt to be a respiratory illness to a multisystem disease with protean
manifestations. Moreover, disparities in outcomes have been described with African Americans
having higher infection and mortality rates. Populations residing in rural areas are often poorer,
older, and have multiple co-morbidities such as type 2 diabetes, obesity and hypertension, raising
questions about disease manifestations and outcomes that may differ from those described in
urban areas. COVID-19 cases and mortality in rural areas continues to climb with multiple
outbreaks, many of which have been related to meat packing plants and prison clusters. The
National COVID Cohort Collaborative (N3C) has been established by the National Center for Data
to Health (CD2H) in partnership with the National Center for Advancing Translational Sciences
(NCATS) for purposes of building a centralized national data resource for the study of COVID-19.
As N3C will facilitate translation of data into knowledge urgently needed to effectively address the
COVID-19 pandemic, it is critically important that this resource contain patient outcomes data
from diverse populations throughout the US – both urban and rural – with inclusion of populations
of color, Native Americans, and others. The Institutional Development Award Program Clinical
Translational Research Centers (IDeA CTRs) are located in diverse areas of the US, serving rural
populations as well as other vulnerable groups, including Native Americans and persons of color.
IDeA CTRs are well poised to provide outcomes data that relate to a diverse group of medically
underserved persons that may otherwise not receive adequate representation in the N3C.
Specifically, eight IDeA CTRs located in Delaware, Louisiana, Maine, Mississippi, Nebraska,
Oklahoma, Rhode Island, and West Virginia have established relationships with healthcare
organizations that have, to date, have conducted SARS CoV-2 testing among more than 285,000
persons, of whom more than 25,000 have tested positive. This project will enable rapid
contribution of COVID-19 patient data from IDeA states to N3C, enhancing understanding of
COVID-19 in the US and driving further research addressing COVID-19 patient outcomes in
multiple underserved populations.

## Key facts

- **NIH application ID:** 10210187
- **Project number:** 3U54GM104942-05S2
- **Recipient organization:** WEST VIRGINIA UNIVERSITY
- **Principal Investigator:** Sally Lynn Hodder
- **Activity code:** U54 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $1,573,155
- **Award type:** 3
- **Project period:** 2012-08-15 → 2022-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10210187

## Citation

> US National Institutes of Health, RePORTER application 10210187, West Virginia Clinical and Translational Science Institute: Improving Health through Partnerships and Transformative Research (3U54GM104942-05S2). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10210187. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*